A methodological framework to enhance the clinical success of cancer immunotherapy

Nat Biotechnol. 2011 Oct 13;29(10):867-70. doi: 10.1038/nbt.2000.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers, Tumor / immunology
  • CTLA-4 Antigen / immunology
  • Clinical Trials as Topic
  • Guidelines as Topic
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / legislation & jurisprudence
  • Immunotherapy / methods*
  • Neoplasms / immunology*
  • Neoplasms / therapy*
  • Publications
  • Survival Analysis
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • CTLA-4 Antigen